Abstract:Hepatitis B virus X protein (HBx) plays crucial roles in hepatocarcinogenesis. However, the underlying mechanism remains elusive. We have reported that HBx is able to up-regulate survivin in hepatocellular carcinoma tissues. The oncopreotein hepatitis B X-interacting protein (HBXIP), a target of miR-520b, is involved in the development of cancer. In this study, we focus on the investigation of hepatocarcinogenesis mediated by HBx. The expression of HBx and survivin was examined in the liver tissues of HBx-Tg mice. The effect of HBx/survivin on the growth of LO2-X-S cells was determined by colony formation and transplantation in nude mice. The effect of HBx/survivin on promoter of miR-520b was determined by Western blot analysis, luciferase reporter gene assay, co-immunoprecipitation (co-IP) and chromatin immunoprecipitation (ChIP), respectively. The expression of HBx, survivin and HBXIP was detected by immunohistochemistry and real-time PCR in clinical HCC tissues, respectively. The DNA demethylation of HBXIP promoter was examined. The functional influence of miR-520b and HBXIP on proliferation of hepatoma cells was analyzed by MTT, colony formation, EdU and transplantation in nude mice in vitro and in vivo. In this study, we provided evidence that HBx up-regulated survivin in the liver cancer tissues of HBx-Tg mice aged 18 M. The engineered LO2 cell lines with survivin and/or HBx were successfully established, termed LO2-X-S. MiR-520b was down-regulated in LO2-X-S cells and clinical HCC tissues. Our data revealed that HBx survivin-dependently down-regulated miR-520b through interacting with Sp1 in the cells. HBXIP was highly expressed in LO2-X-S cells, liver cancer tissues of HBx-Tg mice aged 18 M and clinical HCC tissues (75.17%, 112/149). The expression level of HBXIP was positively associated with those of HBx or survivin in clinical HCC tissues. In addition, we showed that HBx survivin-dependently up-regulated HBXIP through inducing demethylation of HBXIP promoter in LO2-X-S cells and clinical HCC tissues. In function, low level miR-520b and high level HBXIP mediated by HBx with partner survivin contributed to the growth of LO2-X-S cells in vitro and in vivo. HBx accelerates hepatocarcinogenesis with partner survivin through modulating tumor suppressor miR-520b and oncoprotein HBXIP.

The Oncoprotein HBXIP Uses Two Pathways to Up-regulate S100A4 in Promotion of Growth and Migration of Breast Cancer Cells

The Oncoprotein HBXIP Facilitates Metastasis of Hepatocellular Carcinoma Cells by Activation of MMP15 Expression

Hepatitis B virus X protein promotes hepatoma cell invasion and metastasis by stabilizing Snail protein

The modulation of PD-L1 induced by the oncogenic HBXIP for breast cancer growth

Inflammatory factor TNF-α promotes the growth of breast cancer via the positive feedback loop of TNFR1/NF-κB (and/or p38)/p-STAT3/HBXIP/TNFR1

HBXIP Upregulates CD46, CD55 and CD59 Through ERK1/2/NF-κB Signaling to Protect Breast Cancer Cells from Complement Attack

Upregulation of INHBA Mediated by the Transcription Factor BHLHE40 Promotes Colon Cancer Cell Proliferation and Migration

Research progress on oncoprotein hepatitis B X‐interacting protein (Review)

MYBBP1A‑mediated IGFBP4 Promoter Methylation Promotes Epithelial‑mesenchymal Transition and Metastasis Through Activation of NOTCH Pathway in Liver Cancer

Hepatitis B Virus X Protein Accelerates Hepatocarcinogenesis with Partner Survivin Through Modulating Mir-520B and HBXIP

The Role of XBP1s in the Metastasis and Prognosis of Hepatocellular Carcinoma

HBXIP blocks myosin-IIA assembly by phosphorylating and interacting with NMHC-IIA in breast cancer metastasis

SOX4 promotes the growth and metastasis of breast cancer

Hbx Elevates Oncoprotein Aeg-1 Expression to Promote Cell Migration by Downregulating Mir-375 and Mir-136 in Malignant Hepatocytes

S100A4 promotes pancreatic cancer progression through a dual signaling pathway mediated by Src and focal adhesion kinase

Data from HMGN5 Escorts Oncogenic STAT3 Signaling by Regulating the Chromatin Landscape in Breast Cancer Tumorigenesis

Osterix Promotes the Migration and Angiogenesis of Breast Cancer by Upregulation of S100A4 Expression

Promotion of Transcriptional Activity of NF-κB Mediated by HBXIP in Hepatoma Cells

Promotion of cell proliferation by HBXIP via upregulation of human telomerase reverse transcriptase in human mesenchymal stem cells

HPIP is upregulated in liver cancer and promotes hepatoma cell proliferation via activation of G2/M transition.

HBXIP Regulates Gastric Cancer Glucose Metabolism and Malignancy Through PI3K/AKT and p53 Signaling